India’s pharmaceutical retail market rebounded in November with double-digit growth, driven by increased demand for dermatological and cardiac medications. Respiratory issues, exacerbated by pollution, boosted Foracort sales to Rs 82 crore. Both acute and chronic medications saw 11% growth, and industry volumes rose by 3.5%. Analysts predict continued growth in 2025, fueled by price increases and new drug launches.
Pharma market rebounds, asthma drug top seller
Categories:
Related Post
NBA hits Timberwolves’ Anthony Edwards with fifth fine of seasonNBA hits Timberwolves’ Anthony Edwards with fifth fine of season
Anthony Edwards is one of the highest paid players in the NBA, but his wallet is taking another hit. The league fined the Minnesota Timberwolves star $50,000 for what was
Jana Kramer avoids New Year’s resolutions, prefers this technique for self improvementJana Kramer avoids New Year’s resolutions, prefers this technique for self improvement
Jana Kramer is always looking for ways to better herself. While speaking with Fox News Digital, the actress revealed that although she’s not big on making New Year’s resolutions,